Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer

BackgroundThe gold standard treatment for early-stage endometrial cancer (EC) is hysterectomy with bilateral salpingo-oophorectomy (BSO) with lymphadenectomy. In selected patients desiring pregnancy, fertility-sparing treatment (FST) can be adopted. Our review aims to collect the most incisive studi...

Full description

Bibliographic Details
Main Authors: Carlo Ronsini, Lavinia Mosca, Irene Iavarone, Roberta Nicoletti, Davide Vinci, Raffaela Maria Carotenuto, Francesca Pasanisi, Maria Cristina Solazzo, Pasquale De Franciscis, Marco Torella, Marco La Verde, Nicola Colacurci, Luigi Cobellis, Giuseppe Vizzielli, Stefano Restaino
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
endometrial cancer
fertility
pregnancy outcomes
medroxyprogesterone acetate
levonorgestrel intrauterine device (IUD)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.965029/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.965029/full

Similar Items